IOF Advanced Training Course on Osteoporosis
 |
18th IOF Advanced Training Course on Osteoporosis February 3-5, 2009 Program and registration form will be available here shortly |
The IOF Advanced Training Course on Osteoporosis, taught in English by an internationally renowned faculty, provides a concise and practical overview of the latest knowledge on the physiology, epidemiology, diagnosis and management of osteoporosis. The two-and-a-half day course, held annually in Lyon since 1991, trains up to 200 international participants. Organized by course leader Pierre D. Delmas, the course is aimed at medical professionals as well as participants from pharmaceutical and diagnostic industries. Discussion periods, roundtable discussions and meet-the-professor sessions are included throughout the program to encourage direct interactions between registered participants and faculty members.
The venue is centrally located in Lyon, one of France's largest and most interesting cities.
Up to 20 grants are available to healthcare professionals working with IOF member societies.
TRAINING COURSE FACULTY MEMBERS
S. Boonen, M.L. Bouxsein, C. Cooper , P.D. Delmas, W.H. Dere, J.A. Kanis, M. Lechanteur,
H.W. Minne, S.E. Papapoulos, J.Y. Reginster, R. Rizzoli, P. Szulc
TOPICS COVERED INCLUDE
- Bone structure and function
- Pathophysiology of bone loss
- Biomechanics of age-related fractures
- Definition, epidemiology and social aspects of osteoporosis
- Measurement of bone mass
- Biochemical markers of bone turnover
- New imaging techniques for assessing bone strength
- X-ray vertebral deformities
- Assessment of fracture risk
- Roundtable: Diagnostic tools and strategies for osteoporosis
- Nonpharmacological management of osteoporosis
- Osteoporosis in men
- Corticosteroid-induced osteoporosis
- Calcium, vitamin D and its metabolites in osteoporosis
- Anabolic bone agents
- Roundtable: What is the role of general health program (including exercise) and of intervention on peak bone mass for the prevention of osteoporosis?
- Hormone replacement therapy
- Clinical Use of SERMS and other estrogen analogs
- Roundtable: Hormonal intervention in osteoporosis
- Bisphosphonates: pharmacology and safety
- Clinical use of bisphosphonates in postmenopausal osteoporosis
- Other antiresorptive drugs
- Roundtable: Nonhormonal intervention in osteoporosis
- Mechanism underlying the antifracture efficacy of antiresorptive drugs
- Tumoral bone disease
- Clinical guidelines for the diagnosis and treatment of osteoporosis
- Design of intervention studies in osteoporosis
- Health economics in the context of osteoporosis
- Registration of new drugs for osteoporosis: FDA & CPMP guidelines
- Development of a new drug in osteoporosis: From bench to marketing
